{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:19:17Z","timestamp":1790849957484,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82403496"],"award-info":[{"award-number":["82403496"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82402742"],"award-info":[{"award-number":["82402742"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M750552"],"award-info":[{"award-number":["2024M750552"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["7244402"],"award-info":[{"award-number":["7244402"]}]},{"name":"Shanghai Municipal Science and Technology Project","award":["24ZR1412300"],"award-info":[{"award-number":["24ZR1412300"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["No.320.6750.2023-16-14"],"award-info":[{"award-number":["No.320.6750.2023-16-14"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02449-w","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:35:22Z","timestamp":1759408522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Qingqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6547-3832","authenticated-orcid":false,"given":"Zhihuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"2449_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2449_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"2449_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ L\u00f3pez","year":"2023","unstructured":"L\u00f3pez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2449_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina M, Arrazubi V, Diez M, Tabernero J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2023;20:155\u201370.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2449_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21147\/j.issn.1000-9604.2020.06.03","volume":"32","author":"L Yang","year":"2020","unstructured":"Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, et al. Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32:695\u2013704.","journal-title":"Chin J Cancer Res"},{"key":"2449_CR6","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/sj.onc.1209210","volume":"25","author":"R Iwanaga","year":"2006","unstructured":"Iwanaga R, Komori H, Ishida S, Okamura N, Nakayama K, Nakayama KI, et al. Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners. Oncogene. 2006;25:1786\u201398.","journal-title":"Oncogene"},{"key":"2449_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","volume":"20","author":"A Hafner","year":"2019","unstructured":"Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol. 2019;20:199\u2013210.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2449_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41417-021-00405-6","volume":"29","author":"D Zhang","year":"2022","unstructured":"Zhang D, Yang XJ, Luo QD, Xue L, Chong T. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis. Cancer Gene Ther. 2022;29:1001\u201311.","journal-title":"Cancer Gene Ther"},{"key":"2449_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/nar\/gkq762","volume":"39","author":"M Taura","year":"2011","unstructured":"Taura M, Suico MA, Fukuda R, Koga T, Shuto T, Sato T, et al. MEF\/ELF4 transactivation by E2F1 is inhibited by p53. Nucleic Acids Res. 2011;39:76\u201388.","journal-title":"Nucleic Acids Res"},{"key":"2449_CR10","first-page":"5","volume":"14","author":"RD Meng","year":"1999","unstructured":"Meng RD, Phillips P, El-Deiry WS. P53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol. 1999;14:5\u201314.","journal-title":"Int J Oncol"},{"key":"2449_CR11","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.1128\/MCB.15.12.6864","volume":"15","author":"SW Hiebert","year":"1995","unstructured":"Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G, et al. E2f-1:dp-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol. 1995;15:6864\u201374.","journal-title":"Mol Cell Biol"},{"key":"2449_CR12","doi-asserted-by":"publisher","first-page":"13191","DOI":"10.2147\/OTT.S286867","volume":"13","author":"X Zhu","year":"2020","unstructured":"Zhu X, Liao Y, Tang L. Targeting BRD9 for cancer treatment: a new strategy. Onco Targets Ther. 2020;13:13191\u2013200.","journal-title":"Onco Targets Ther"},{"key":"2449_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1543","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Gao Z, Mohd-Ibrahim I, Yang H, Wu L, Fu Y, et al. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours. Clin Transl Med. 2024;14:e1543.","journal-title":"Clin Transl Med"},{"key":"2449_CR14","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41467-019-09891-7","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Wang S, Troisi EC, Howard TP, Haswell JR, Wolf BK, et al. BRD9 defines a SWI\/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors. Nat Commun. 2019;10:1881.","journal-title":"Nat Commun"},{"key":"2449_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2018.05.002","volume":"33","author":"MJ McBride","year":"2018","unstructured":"McBride MJ, Pulice JL, Beird HC, Ingram DR, D\u2019Avino AR, Shern JF, et al. The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell. 2018;33:1128\u2013e11411127.","journal-title":"Cancer Cell"},{"key":"2449_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2023.09.021","volume":"166","author":"Y Feng","year":"2024","unstructured":"Feng Y, Cai L, Pook M, Liu F, Chang CH, Mouti MA, et al. BRD9-SMAD2\/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Gastroenterology. 2024;166:139\u201354.","journal-title":"Gastroenterology"},{"key":"2449_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","volume":"81","author":"A Alpsoy","year":"2021","unstructured":"Alpsoy A, Utturkar SM, Carter BC, Dhiman A, Torregrosa-Allen SE, Currie MP, et al. BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. Cancer Res. 2021;81:820\u201333.","journal-title":"Cancer Res"},{"key":"2449_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","volume":"574","author":"D Inoue","year":"2019","unstructured":"Inoue D, Chew GL, Liu B, Michel BC, Pangallo J, D\u2019Avino AR, et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature. 2019;574:432\u20136.","journal-title":"Nature"},{"key":"2449_CR19","doi-asserted-by":"publisher","unstructured":"Hansen A, Sanders C, Fronhoffs F, Funke K, Kristiansen G, Schorle H. BRD9 Inhibition as potential treatment option for testicular germ cell tumors. Andrology. 2025;1\u201314. https:\/\/doi.org\/10.1111\/andr.70038.","DOI":"10.1111\/andr.70038"},{"key":"2449_CR20","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/s41467-020-16443-x","volume":"11","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Huang J, Zhang C, Zhao F, Kim W, Tu X, et al. The bromodomain containing protein BRD-9 orchestrates RAD51-RAD54 complex formation and regulates homologous recombination-mediated repair. Nat Commun. 2020;11:2639.","journal-title":"Nat Commun"},{"key":"2449_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"MB Kastan","year":"2004","unstructured":"Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316\u201323.","journal-title":"Nature"},{"key":"2449_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejs\u00ed Z, Koed K, Kr\u00e4mer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864\u201370.","journal-title":"Nature"},{"key":"2449_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccell.2018.01.019","volume":"33","author":"C Sun","year":"2018","unstructured":"Sun C, Yin J, Fang Y, Chen J, Jeong KJ, Chen X, et al. BRD4 Inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency. Cancer Cell. 2018;33:401\u2013e416408.","journal-title":"Cancer Cell"},{"key":"2449_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1101\/gad.252189.114","volume":"29","author":"F Gong","year":"2015","unstructured":"Gong F, Chiu LY, Cox B, Aymard F, Clouaire T, Leung JW, et al. Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. Genes Dev. 2015;29:197\u2013211.","journal-title":"Genes Dev"},{"key":"2449_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-022-05551-x","volume":"613","author":"X Sun","year":"2023","unstructured":"Sun X, Klingbeil O, Lu B, Wu C, Ballon C, Ouyang M, et al. BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network. Nature. 2023;613:195\u2013202.","journal-title":"Nature"},{"key":"2449_CR26","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1158\/2159-8290.CD-23-0601","volume":"13","author":"G Efe","year":"2023","unstructured":"Efe G, Dunbar KJ, Sugiura K, Cunningham K, Carcamo S, Karaiskos S, et al. P53 gain-of-function mutation induces metastasis via BRD4-dependent CSF-1 expression. Cancer Discov. 2023;13:2632\u201351.","journal-title":"Cancer Discov"},{"key":"2449_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116994","volume":"280","author":"D Fabra","year":"2024","unstructured":"Fabra D, Melones-Herrero J, Velazquez-Gutierrez J, Matesanz AI, Aliseda PD, Figueiras S, et al. A select thiosemicarbazone copper(II) complex induces apoptosis in gastric cancer and targets cancer stem cells reducing pluripotency markers. Eur J Med Chem. 2024;280:116994.","journal-title":"Eur J Med Chem"},{"key":"2449_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16:57.","journal-title":"J Hematol Oncol"},{"key":"2449_CR29","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"2449_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrm.2016.143","volume":"18","author":"T Fujisawa","year":"2017","unstructured":"Fujisawa T, Filippakopoulos P. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. Nat Rev Mol Cell Biol. 2017;18:246\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2449_CR31","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.neo.2024.101046","volume":"57","author":"DS Chandrashekar","year":"2024","unstructured":"Chandrashekar DS, Afaq F, Karthikeyan SK, Athar M, Shrestha S, Singh R, et al. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells. Neoplasia. 2024;57:101046.","journal-title":"Neoplasia"},{"key":"2449_CR32","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-22-3668","volume":"29","author":"K Kurata","year":"2023","unstructured":"Kurata K, Samur MK, Liow P, Wen K, Yamamoto L, Liu J, et al. Brd9 degradation disrupts ribosome biogenesis in multiple myeloma. Clin Cancer Res. 2023;29:1807\u201321.","journal-title":"Clin Cancer Res"},{"key":"2449_CR33","doi-asserted-by":"publisher","unstructured":"Brien GL, Remillard D, Shi J, Hemming ML, Chabon J, Wynne K, et al. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma. Elife. 2018;7:e41305. https:\/\/doi.org\/10.7554\/eLife.41305.","DOI":"10.7554\/eLife.41305"},{"key":"2449_CR34","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.1093\/nar\/gkad907","volume":"51","author":"X Wang","year":"2023","unstructured":"Wang X, Song C, Ye Y, Gu Y, Li X, Chen P, et al. BRD9-mediated control of the TGF-\u03b2\/Activin\/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells. Nucleic Acids Res. 2023;51:11634\u201351.","journal-title":"Nucleic Acids Res"},{"key":"2449_CR35","doi-asserted-by":"publisher","first-page":"8214","DOI":"10.1093\/nar\/gkab643","volume":"49","author":"C Wang","year":"2021","unstructured":"Wang C, Tang M, Chen Z, Nie L, Li S, Xiong Y, et al. Genetic vulnerabilities upon inhibition of DNA damage response. Nucleic Acids Res. 2021;49:8214\u201331.","journal-title":"Nucleic Acids Res"},{"key":"2449_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13020-024-00982-2","volume":"19","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li Q, Huang Y, Yang Z, Li G, Sun X, et al. Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance. Chin Med. 2024;19:110.","journal-title":"Chin Med"},{"key":"2449_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70602","volume":"14","author":"ZZ Zhou","year":"2025","unstructured":"Zhou ZZ, Lu JC, Guo SB, Tian XP, Li HL, Zhou H, et al. A mitochondria-related signature in diffuse large B-cell lymphoma: prognosis, immune and therapeutic features. Cancer Med. 2025;14:e70602.","journal-title":"Cancer Med"},{"key":"2449_CR38","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1021\/acs.jmedchem.5b01865","volume":"59","author":"LJ Martin","year":"2016","unstructured":"Martin LJ, Koegl M, Bader G, Cockcroft XL, Fedorov O, Fiegen D, et al. Structure-based design of an in vivo active selective BRD9 inhibitor. J Med Chem. 2016;59:4462\u201375.","journal-title":"J Med Chem"},{"key":"2449_CR39","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1002\/anie.201501394","volume":"54","author":"PG Clark","year":"2015","unstructured":"Clark PG, Vieira LC, Tallant C, Fedorov O, Singleton DC, Rogers CM, et al. LP99: discovery and synthesis of the first selective BRD7\/9 bromodomain inhibitor. Angew Chem Int Ed Engl. 2015;54:6217\u201321.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2449_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45:592\u2013601.","journal-title":"Nat Genet"},{"key":"2449_CR41","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ccell.2024.06.012","volume":"42","author":"L Duplaquet","year":"2024","unstructured":"Duplaquet L, So K, Ying AW, Pal Choudhuri S, Li X, Xu GD, et al. Mammalian SWI\/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. Cancer Cell. 2024;42:1352\u2013e13691313.","journal-title":"Cancer Cell"},{"key":"2449_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41419-019-1570-9","volume":"10","author":"N Del Gaudio","year":"2019","unstructured":"Del Gaudio N, Di Costanzo A, Liu NQ, Conte L, Migliaccio A, Vermeulen M, et al. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition. Cell Death Dis. 2019;10:338.","journal-title":"Cell Death Dis"},{"key":"2449_CR43","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nchembio.2115","volume":"12","author":"AF Hohmann","year":"2016","unstructured":"Hohmann AF, Martin LJ, Minder JL, Roe JS, Shi J, Steurer S, et al. Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition. Nat Chem Biol. 2016;12:672\u20139.","journal-title":"Nat Chem Biol"},{"key":"2449_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2019.01.007","volume":"446","author":"H Huang","year":"2019","unstructured":"Huang H, Wang Y, Li Q, Fei X, Ma H, Hu R. Mir-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9. Cancer Lett. 2019;446:81\u20139.","journal-title":"Cancer Lett"},{"key":"2449_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cpt.2024.06.002","volume":"2","author":"Z Gao","year":"2024","unstructured":"Gao Z, Shen Z, Wang S, Ye Y. New insights into digestive tract tumors. Cancer Pathogenesis and Therapy. 2024;2:217\u20138.","journal-title":"Cancer Pathogenesis and Therapy"},{"key":"2449_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"key":"2449_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1574892818666230522161742","volume":"19","author":"F Kong","year":"2024","unstructured":"Kong F, Zhao L, Wang N, Zhang D, Wang Z, Mei Q, et al. The FJQR has synergistic effect with fluoropyrimidine in the maintenance treatment for HER-2 negative gastric cancer. Recent Pat Anticancer Drug Discov. 2024;19:165\u201375.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"2449_CR48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s42003-024-06052-5","volume":"7","author":"J Melones-Herrero","year":"2024","unstructured":"Melones-Herrero J, Alcal\u00e1 S, Ruiz-Ca\u00f1as L, Ben\u00edtez-Buelga C, Batres-Ramos S, Cal\u00e9s C, et al. Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells. Commun Biol. 2024;7:353.","journal-title":"Commun Biol"},{"key":"2449_CR49","doi-asserted-by":"publisher","unstructured":"Melones-Herrero J, Delgado-Aliseda P, Figueiras S, Velazquez-Gutierrez J, Quiroga AG, Cales C, et al. Trans-[Pt(amine)Cl(2)(PPh(3))] complexes target mitochondria and Endoplasmic reticulum in gastric cancer cells. Int J Mol Sci. 2024;25(14):7739. https:\/\/doi.org\/10.3390\/ijms25147739.","DOI":"10.3390\/ijms25147739"},{"key":"2449_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2478\/jtim-2023-0103","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang J, Zhao G, Zhao Y, Zhao Z, Yang S, Zhou A, et al. N(6)-methylation in the development, diagnosis, and treatment of gastric cancer. J Transl Intern Med. 2024;12:5\u201321.","journal-title":"J Transl Intern Med"},{"key":"2449_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","journal-title":"Drug Resist Updat"},{"key":"2449_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216659","volume":"587","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu L, Tian Y, Gu M, Wang Y, Ashrafizadeh M, et al. Autophagy-driven regulation of cisplatin response in human cancers: exploring molecular and cell death dynamics. Cancer Lett. 2024;587:216659.","journal-title":"Cancer Lett"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02449-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:02:56Z","timestamp":1759413776000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02449-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2449"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02449-w","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical samples and information used in the study was approved by the Institutional Review Board of Fudan University Shanghai Cancer Center. The animal experiments were conducted in compliance with protocols approved by the Shanghai Medical Experimental Animal Care Commission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}